pre-update Archives

On-Demand Webinar

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a…

CertaraJanuary 13, 2022

Blog

When Should I Select an eCTD Vendor for My Regulatory Submission?

As your company moves towards the regulatory submission of a marketing application to a health…

CertaraJanuary 10, 2022

On-Demand Webinar

Certara University Express Webinar: Part 2: Introduction to RsNLME and overview of expanded workflow

Introduction to RsNLME and its capabilities for population PK/PD modeling.

CertaraJanuary 5, 2022

On-Demand Webinar

Certara University Express Webinar: Part 1: Introduction to RsNLME (R speaks NLME)

Introduction to RsNLME and its capabilities for population PK/PD modeling.

CertaraJanuary 5, 2022

Announcement

Certara Acquires Integrated Nonclinical Development Solutions

Expands software portfolio and nonclinical drug development expertise PRINCETON, N.J.— Jan 5, 2022– Certara, Inc.,…

CertaraJanuary 5, 2022

White Paper

Moving Advanced Therapies to the Next Level – Tackling the Key Challenges When Transitioning from Nonclinical to Clinical Development

CertaraDecember 23, 2021

On-Demand Webinar

Strategic Application of PBPK Modeling for Predicting DDIs & the Effects of Smoking & Organ Impairment

Olanzapine is a highly effective antipsychotic, but its uses are limited by the risk of…

CertaraDecember 23, 2021

Publication

ScienceDirect: Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial

Observational studies have postulated a therapeutic role of metformin in treating COVID-19. We conducted ...(cont.)

CertaraDecember 22, 2021

Press Release

Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions

FDA holds more than 400 SimcypTM and PhoenixTM software licenses across 12 divisions and offices…

CertaraDecember 21, 2021

Announcement

P21 Releases New PMDA Validation Engine

New PMDA Engine Pinnacle 21 is happy to announce the latest Validation Engine for submissions…

CertaraDecember 20, 2021

pre-update

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

When Should I Select an eCTD Vendor for My Regulatory Submission?

Certara University Express Webinar: Part 2: Introduction to RsNLME and overview of expanded workflow

Certara University Express Webinar: Part 1: Introduction to RsNLME (R speaks NLME)

Certara Acquires Integrated Nonclinical Development Solutions

Moving Advanced Therapies to the Next Level – Tackling the Key Challenges When Transitioning from Nonclinical to Clinical Development

Strategic Application of PBPK Modeling for Predicting DDIs & the Effects of Smoking & Organ Impairment

ScienceDirect: Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial

Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions

P21 Releases New PMDA Validation Engine

Newsletter sign up

Quick links

Solutions

Contact